• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10619
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Angina (1710)
Event Date 06/14/2023
Event Type  Injury  
Event Description
It was reported that patient experienced unstable angina pectoris.On (b)(6), 2022, the subject presented with stable angina and was referred for cardiac catheterization and the index procedure was performed on the same day.The target lesion# 1 was located in the 1st diagonal with 80% stenosis and was 18 mm long, with a reference vessel diameter of 2.25 mm.The target lesion# 1 was treated with pre-dilatation and placement of a 2.25 mm x 20 mm synergy stent system.Following post-dilatation, the residual stenosis was noted to be 0%.The target lesion# 2 was located in the left main coronary artery (lcma) extending up to distal left anterior descending artery (lad) with 80% stenosis and was 52 mm long, with a reference vessel diameter of 4.0 mm.The target lesion# 2 was treated with pre-dilatation and placement of a 4.0 mm x 32 mm synergy stent system.Following post-dilatation, the residual stenosis was noted to be 0%.Nine days later, the subject was discharged on aspirin and clopidogrel.On (b)(6), 2023, the subject was diagnosed with stable angina pectoris and was hospitalized on the same day for further evaluation and treatment.No other action was taken to treat the event and site confirmed the same.Seven days later, the subject was discharged on aspirin and clopidogrel.At the time of reporting the event was considered to be recovering/resolving.No additional information would be available pertaining to the event at the moment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17371630
MDR Text Key319502265
Report Number2124215-2023-36229
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/11/2023
Device Model Number10619
Device Catalogue Number10619
Device Lot Number0028225110
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/11/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization;
Patient Age57 YR
Patient SexMale
-
-